Clozapine clinical toolkit optimizes inpatient clozapine monitoring

• Главные авторы: Brooke Gessner, PharmD, ACPR (Автор), Michelle Carter, RN, MSN (Автор), Kiana Rahnama, BSc, PharmD, ACPR (Автор), Alberto Almeida, MPH, PMP (Автор), Colleen Borralho, MHS, BSPN, BA, RPN (Автор), Tamara Mihic, BSc, ACPR, PharmD (Автор), Joan C. Y. Ng, BSc, ACPR, PharmD (Автор), Joseph H. Puyat, MA, MSc, PhD (Автор), Angela Russolillo, PhD, MSc, RPN (Автор), Katelyn C. Halpape, BSP, ACPR, PharmD, BCPP (Автор)
• Формат: ‌
• Опубликовано: American Association of Psychiatric Pharmacists, 2024-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Introduction Clozapine is the most effective antipsychotic in the management of treatment-resistant schizophrenia; however, its use is challenging due to the risk of severe adverse effects. Despite the risks associated with clozapine, there is no mandatory monitoring in Canada beyond hematologic tes...